0001209191-23-013280.txt : 20230227 0001209191-23-013280.hdr.sgml : 20230227 20230227171616 ACCESSION NUMBER: 0001209191-23-013280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230227 DATE AS OF CHANGE: 20230227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gao Hanlin CENTRAL INDEX KEY: 0001684532 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37894 FILM NUMBER: 23676598 MAIL ADDRESS: STREET 1: 2325 CLUB VISTA DRIVE CITY: GLENDORA STATE: CA ZIP: 91741 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulgent Genetics, Inc. CENTRAL INDEX KEY: 0001674930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 812621304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 BUSINESS PHONE: 626-350-0537 MAIL ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 FORMER COMPANY: FORMER CONFORMED NAME: Fulgent Diagnostics, Inc. DATE OF NAME CHANGE: 20160517 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-23 0 0001674930 Fulgent Genetics, Inc. FLGT 0001684532 Gao Hanlin C/O FULGENT GENETICS, INC. 4978 SANTA ANITA AVE, STE 205 TEMPLE CITY CA 91780 0 1 0 0 Chief Scientific Officer Common Stock 2023-02-23 4 A 0 2142 0.00 A 908254 D Common Stock 2023-02-23 4 A 0 12156 0.00 A 920410 D Common Stock 2023-02-23 4 F 0 794 31.65 D 919616 D Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022. Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022. /s/ Paul Kim as Attorney-in-Fact 2023-02-27